Haleon To Sell Nicotine Replacement Biz For Up To £500M
Haleon PLC said Wednesday that it will sell its nicotine replacement business outside the U.S. to Indian pharmaceutical group Dr. Reddy's Laboratories for up to £500 million ($632 million) to streamline...To view the full article, register now.
Already a subscriber? Click here to view full article